	ALK rearrangements and resistance mutations in non-small cell lung cancer: molecular mechanisms and therapeutic implications. Cancer Chemother Pharmacol Bharath P, Iyer S, Velu AV, Kumar DT. PMID: 42371103 [PubMed - indexed for MEDLINE]
	CD68(+) tumor-associated macrophages exhibit prognostic value in surgically resected small cell lung cancer: a retrospective cohort study of 614 patients. Cancer Immunol Immunother Ma R, Tu H, Wang X, Wu P, Liu L, Gu X, Li D, Shang D, Zhang G, Zhang C, Sun N, He J. PMID: 42371090 [PubMed - as supplied by publisher]
	Current and emerging therapies targeting cell surface antigens and epigenetics in extensive stage small cell lung cancer: primer for clinicians. Ther Adv Med Oncol Hao Z, Villano J, Arnold SM, Anthony L. PMID: 42369724 [PubMed]
	Physical activity trajectories and associated factors in patients with lung cancer undergoing chemotherapy: A longitudinal study. Asia Pac J Oncol Nurs Cao Z, Ding M, Xu Q, Zhang Y, Wang Z, Hong J. PMID: 42369381 [PubMed]
	The predictive value of (18)F-FDG PET/CT habitat radiomics combined model in evaluating EGFR gene mutations in lung adenocarcinoma. Front Med (Lausanne) Lai R, Sheng D, Geng Y, Ding C, Tan Q, Zhao L. PMID: 42369164 [PubMed]
	Advantages and research progress of three-dimensional culture systems for lung cancer drug screening (Review). Oncol Lett Tian Y, Liu H, Zhang M, Cui A, Chen H, Shi L, Zhu J, Li M, Wang B, Huang H, Yang J. PMID: 42368550 [PubMed]
	Systems-level analyses and clinical validation highlight CD53 as a diagnostic and prognostic marker in lung adenocarcinoma. Front Cell Dev Biol Chen J, Tan W, Wei Y, Han Z, Zhu J, Wei K. PMID: 42368459 [PubMed]
	Advances in neoadjuvant immunotherapy for non-small cell lung cancer. Front Immunol Liu X, Li H, Dong G, Liu Y, Ran M, Wang D. PMID: 42367815 [PubMed - indexed for MEDLINE]
	Tislelizumab-induced distal renal tubular acidosis presenting with life-threatening hypokalemia: a case report. Front Immunol Xu J, Qin L, Wang P, Liu Z, Yang L, Zhang H, Wang Y, Gao J, Zhao M, Zhang K. PMID: 42367811 [PubMed - indexed for MEDLINE]
	Neoadjuvant PD-1/VEGF bispecific antibody combined with chemotherapy for locally advanced pulmonary lymphoepithelioma-like carcinoma achieving pathological complete response: a case report and literature review. Front Immunol You Y, Yang M, Chen Z, Wu X, Dong W. PMID: 42367792 [PubMed - indexed for MEDLINE]
	Peripheral immune cell subsets as potential predictors of benefit from immune checkpoint blockade therapy in small cell lung cancer. Front Immunol Galindo-Campos MA, Hardy-Werbin M, Gibert J, Pucci M, Hernández-Prat A, Ríos-Hoyo A, Rocha P, Rossell A, Del Rey-Vergara R, Parreira A, Pellicer A, Taus Á, Rovira A, Arriola E. PMID: 42367772 [PubMed - indexed for MEDLINE]
	HLA-G expression in non-small cell lung cancer: prognostic significance and interplay with PD-L1 and CD8(+) tumor-infiltrating lymphocytes. Front Immunol Querzoli G, Bogina G, Marconi M, Tumino N, Vacca P, Righi L, Pilotto S, Caliò A, Cima L, Gobbo S, Cecchini MJ, Paolino G, Ciompi F, Accolla RS, Scarpa A, Lunardi G, Marcenaro E, Moretta L, Zamboni G, Munari E. PMID: 42367769 [PubMed - indexed for MEDLINE]
	Chronic Obstructive Pulmonary Disease Influence on Lung Cancer Risk Through Blood Metabolite Mediation: A Two-Sample Mendelian Randomisation and Mediation Analysis. Int J Chron Obstruct Pulmon Dis Cao YN, Wang L, Fan HS, Zhang ZJ. PMID: 42367346 [PubMed - indexed for MEDLINE]
	Chemotherapy-induced peripheral neuropathy associated with docetaxel or nab-paclitaxel among patients with lung cancer: a prospective dual-center cohort study. Front Pharmacol Liu Y, Li Y, Li X, Zhang H, Liu X, Chen P. PMID: 42367306 [PubMed]
	Efficacy and safety of nab-paclitaxel in advanced or recurrent small cell lung cancer: a single-arm meta-analysis. Front Pharmacol Liu JC, Yu HJ, Chen Z, Deng Q. PMID: 42367288 [PubMed]
	Pulmonary NUT carcinoma mimicking small cell lung cancer: a diagnostic pitfall in high-grade thoracic tumors. Indian J Thorac Cardiovasc Surg Jain S, Osama MA, Bal S. PMID: 42367274 [PubMed]
	Decision-Making Readiness and Its Influencing Factors Among Lung Cancer Patients Receiving Chemotherapy: A Cross-Sectional Study. Nurs Open Wang Y, Li J, Quan Y, Zhai M, Hu X, Wang P, Zhong J, Wang J, Sun X. PMID: 42366843 [PubMed - indexed for MEDLINE]
	Peruvoside, a cardiac glycoside, induces cell cycle arrest in non-small cell lung cancer (A549 cell line) and modulates PI3K/AKT/mTOR. J Complement Integr Med Ahmed ZS, Jasem MA, Abdul-Razzaq Mshimesh B, Al-Qaysi SA. PMID: 42366771 [PubMed - as supplied by publisher]
	Biomarker testing patterns among patients newly diagnosed with metastatic non-small cell lung cancer, prostate cancer, and bladder cancer. Oncologist Mahmud S, Dwyer Orr L, Cline M, Mirsalehi A, Lisi M, Ensley L, Brisbin L, Paulson RS. PMID: 42366674 [PubMed - as supplied by publisher]
	Diagnostic Value of CCL2 and CCR2 in Pleural Effusion for Distinguishing Lung Cancer Histological Subtypes: A Retrospective Study. Diagn Cytopathol Yu J, Huang Y, Chen W. PMID: 42366584 [PubMed - as supplied by publisher]

Articles 1 - 20 / 161048

Page 1 of 8053



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy